Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New biologically dynamic hybrid pharmacophore triazinoindole-based-thiadiazole as potent α-glucosidase inhibitors: In vitro and in silico study
Aftab Ahmad Khan, Fazal Rahim, Muhammad Taha, et al.
International Journal of Biological Macromolecules (2021) Vol. 199, pp. 77-85
Closed Access | Times Cited: 16

Showing 16 citing articles:

Synthetic α-glucosidase inhibitors as promising anti-diabetic agents: Recent developments and future challenges
Alia Mushtaq, Uzma Azam, Saba Mehreen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115119-115119
Closed Access | Times Cited: 100
Diverse Biological Activities of 1,3,4-Thiadiazole Scaffold
Tulika Anthwal, Sarvesh Paliwal, Sumitra Nain
Chemistry (2022) Vol. 4, Iss. 4, pp. 1654-1671
Open Access | Times Cited: 35
Thiadiazole based triazole/hydrazone derivatives: Synthesis, in vitro α-glucosidase inhibitory activity and in silico molecular docking study
Fazal Rahim, Hayat Ullah, Rafaqat Hussain, et al.
Journal of Molecular Structure (2023) Vol. 1287, pp. 135619-135619
Closed Access | Times Cited: 27
Inhibition effect of AGEs formation in vitro by the two novel peptides EDYGA and DLLCIC derived from Pelodiscus sinensis
Nuo Chen, Nan Wang, Qingwei Fang, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Synthesis, in vitro biological assessment, and molecular docking study of benzimidazole-based thiadiazole derivatives as dual inhibitors of α-amylase and α-glucosidase
Shoaib Khan, Shahid Iqbal, Muhammad Taha, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 19
Recent Studies of Nitrogen and Sulfur Containing Heterocyclic Analogues as Novel Antidiabetic Agents: A Review
Shankar Gharge, Shankar G. Alegaon
Chemistry & Biodiversity (2023) Vol. 21, Iss. 2
Closed Access | Times Cited: 15
Synthesis, in Vitro Bio-Evaluation and in Silico Molecular Docking Studies of Thiadiazole-Based Schiff Base Derivatives
Yousaf Khan, Aneela Maalik, Wajid Rehman, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 4, pp. 335-348
Closed Access | Times Cited: 5
Molecular iodine-promoted oxidative cyclization for the synthesis of 1,3,4-thiadiazole-fused- [1,2,4]-thiadiazole incorporating 1,4-benzodioxine moiety as potent inhibitors of α-amylase and α-glucosidase: In vitro and in silico study
Rafaqat Hussain, Mazloom Shah, Shahid Iqbal, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 21
Emerging synthetic Strategies and Pharmacological Insights of 1,3,4-Thiadiazole Derivatives: A Comprehensive Review
Davinder Kumar, Navidha Aggarwal, Virender Kumar, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 6, pp. 563-581
Closed Access | Times Cited: 3
A combined in vitro and in silico approach of thiadiazole based Schiff base derivatives as multipotent inhibitor: Synthesis, spectral analysis, antidiabetic and antimicrobial activity
Tayyaba Zahoor, Shoaib Khan, Sampath Chinnam, et al.
Results in Chemistry (2024) Vol. 9, pp. 101671-101671
Open Access | Times Cited: 1
Inhibition of α-glucosidase Enzyme By ‘click'-inspired Pharmacophore Framework 1,3,4-thiadiazole–1,2,3-triazole Hybrids
Manoj Dhameja, Hariom Kumar, Sirisha Kurella, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 4, pp. 345-363
Closed Access | Times Cited: 4
Gaining deeper insights into 2,5-disubstituted furan derivatives as potent α-glucosidase inhibitors and discovery of putative targets associated with diabetes diseases using an integrative computational approach
Wahyu Eko Prasetyo, Triana Kusumaningsih, Fajar Rakhman Wibowo
Structural Chemistry (2022) Vol. 34, Iss. 2, pp. 519-538
Closed Access | Times Cited: 5
Synthesis of 1,2,3‐triazole‐1,3,4‐thiadiazole hybrids as novel α‐glucosidase inhibitors by in situ azidation/click assembly
Hariom Kumar, Manoj Dhameja, Sirisha Kurella, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 8
Closed Access | Times Cited: 2
Imidazole‐thiadiazole hybrids: A multitarget de novo drug design approach, in vitro evaluation, ADME/T, and in silico studies
Maryam Maqbool, Mehwish Solangi, Khalid Mohammed Khan, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 9
Closed Access
Design, synthesis, biological evaluation and molecular docking study of thiadiazole-isatin hybrid analogues as potential anti-diabetic and anti-bacterial agents
Ghada Mohamed Aleid, Shahzad Ahmad Abbasi, Hayat Ullah, et al.
Results in Chemistry (2024), pp. 101805-101805
Open Access
Microwave synthesis and antibacterial assay of new 1,3-thiazolidin-4-one derivatives based on 2-amino-5-mercapto-1,3,4-thiadiazole
Haneen Hadi Abbas, Zeid Hassan Abood
AIP conference proceedings (2023) Vol. 2977, pp. 040069-040069
Closed Access
Page 1

Scroll to top